Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
FloraWorks
AddedFeb 16, 2024
UpdatedJun 18, 2026
FloraWorks

FloraWorks

Series A

FloraWorks: A leading hemp-derived cannabinoid manufacturer, innovating for commercial and therapeutic use.

HQ
Milwaukie, OR, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

FloraWorks, founded with a mission to advance cannabinoid research, focuses on the discovery and commercialization of rare and novel hemp-derived cannabinoids. The company aims to revolutionize therapeutic applications by developing and patenting scalable manufacturing pathways. FloraWorks serves technical biotech enterprises, offering innovative solutions for both commercial and therapeutic markets.

Notable figures affiliated with FloraWorks include experts in biotechnology and cannabinoid research, though specific names are not publicly highlighted. The company has achieved significant milestones in patenting new manufacturing processes and contributing to the growing field of cannabinoid-based therapeutics. FloraWorks' impact is evident in its pioneering role in expanding the possibilities of hemp-derived cannabinoids for diverse applications.

FloraWorks - Similar Companies

Hemp Synergistics logo

Hemp Synergistics

CBD FLA logo

CBD FLA

Growpacker logo

Growpacker

growpacker.com

FireFlower logo

FireFlower

fireflower-usa.com

Central Processors logo

Central Processors

Flora California logo

Flora California

Diverse Biotech logo

Diverse Biotech

The Emerald logo

The Emerald

theemeraldcorp.com

Verda Bio logo

Verda Bio

verdabio.com

Harvest Direct Enterprises logo

Harvest Direct Enterprises

Fluresh logo

Fluresh

fluresh.com

Bloomios logo

Bloomios

Pure Spectrum CBD logo

Pure Spectrum CBD

LeafWorks logo

LeafWorks

leafworks.com

Hemp Hunter Labs logo

Hemp Hunter Labs

FloraWorks - Quick Facts

Who are FloraWorks' competitors?

Companies similar to FloraWorks include Hemp Synergistics, CBD FLA, Growpacker and FireFlower.

When was FloraWorks founded?

FloraWorks was founded in 2020.

Where is FloraWorks' headquarters located?

FloraWorks' headquarters is located in Milwaukie, OR, US.

When was FloraWorks' last funding round?

FloraWorks' most recent funding round was for $2.3M (USD) in December 2022.

How much has FloraWorks raised to-date?

As of Dec 15, 2022, FloraWorks has raised a total of $2.3M (USD).

How many employees does FloraWorks have?

FloraWorks has 11 employees as of Feb 4, 2024.

FloraWorks - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Manufacturing
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Cannabinoids
Tags
  • API
  • Biotech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified